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Article / Clinical Case Report
ABSTRACT
Pulmonary placental transmogrification (PT) is a rare entity with less than 40 cases reported in the literature. Most reported 
cases are associated with either bullous emphysema or with pulmonary fibrochondromatous hamartomas. We present only 
the second case of PT associated with adenocarcinoma of the lung. A 67-year-old female with multiple chronic medical 
ailments presented with shortness of breath and was found to have a 6-cm mass in the upper lobe of her right lung. 
A computed tomography (CT) guided core biopsy was performed that showed a well-differentiated adenocarcinoma. 
Interestingly the normal lung tissue showed placental villous architecture. A unique feature of our case is that the diagnosis 
was made on a needle core biopsy, unlike all the other cases in the literature. We also provide a comprehensive review 
of this rare entity. 
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INTRODUCTION
Pulmonary placental transmogrification (PT) is 
a rare histopathologic entity first described by Mc 
Chesney in 1979.1 PT is a benign lesion and resembles 
placental tissue morphologically, however, lacks the 
functionality of the placenta. It is usually diagnosed 
as an incidental finding, and the exact etiology is still 
unknown. Some think that it is due to lymphatic or 
vascular proliferation in emphysematous lung,2-4 while 
others believe it to be a component of a congenital 
malformation,3 or a hamartoma.1 Xu et al.5 found 
that PT is frequently associated with pulmonary 
fibrochondromatous hamartomas and may be induced 
by or associated with a proliferation of lining epithelial 
components in the hamartomas. Clinically PT is 
associated with the bullous emphysematous disease. 
A thorough literature review revealed one case of 
PT associated with adenocarcinoma of the lung.6 
The PubMed database was searched using keywords 
“placental transmogrification”. 26 manuscripts, 
most of which were case reports were identified. 
All these were analyzed with respect to patient 
demographics, clinical presentation, associated 
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conditions, pathogenic hypotheses, radiologic findings, 
microscopic appearance, treatment modalities and 
prognosis. We report a case of a well-differentiated, 
lepidic predominant adenocarcinoma arising in 
association with PT.
CASE REPORT
A 67-year-old African American female with a 
past medical history of hypertension, diabetes mellitus, 
chronic obstructive pulmonary disease with a smoking 
history of half pack per day for 17 years, seizure 
disorder, chronic liver disease due to hepatitis C, 
multiple GI bleeds and substance abuse (marijuana, 
crack cocaine and heroin) presented to the emergency 
department with shortness of breath. On examination 
patient had decreased breath sounds bilaterally with 
poor inspiratory effort, hepatomegaly and dry mucous 
membranes. Point-of-care glucose was noted to be 
512 mg/dl (NR: 70-199 mg/dl) and oxygen saturation 
was 87% (NR: 90-100%) on room air. On laboratory 
investigations, she was found to be severely anemic 
with hemoglobin of 7.0 g/dl (NR: 12-16 g/dl) and had 
hypophosphatemia. A chest x-ray revealed a vague 
mass-like opacity within the right upper lung zone. 
Since the mass was suspicious for malignancy a CT scan 
was done, that demonstrated a 6 cm irregularly-shaped 
right upper lobe mass with ground glass and solid 
components (Figure 1A and 1B). The lungs were 
diffusely emphysematous.
A CT-guided core biopsy of this lesion was 
performed. Biopsy specimen consisted of flecks of 
tissue 3 × 2 × 1 mm in aggregate, yet it proved 
diagnostic (Figure 2). Microscopic evaluation revealed 
proliferation of atypical, non-mucinous, low columnar 
to hobnail cells with enlarged, hyperchromatic 
nuclei. These cells lined the pre-existing alveolar 
septal architecture which showed slight expansion 
of the interstitium with fibrosis, a pattern referred 
to as “lepidic” growth pattern. Although these 
findings were subtle, yet were sufficient to establish 
a diagnosis of well-differentiated adenocarcinoma 
(Figure 3A and 3B). More interesting than this, was that 
the portion of benign lung tissue showed architectural 
features of placental villi, consistent with pulmonary 
placental transmogrification (Figure 3C and 3D). 
Limited by the fact that the specimen was a core 
biopsy, it could not be determined with certainty 
Figure 2. Low magnification (H&E, 40X) view of the 
entire specimen showing the fragment involved by 
well-differentiated adenocarcinoma and classic PT changes.
Figure 1. Thoracic CT showing right upper lobe mass 
with solid and ground glass components in a background 
of diffusely emphysematous lungs. (A - coronal plane; 
B - axial plane).
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whether the benign PT changes were within the mass 
or arose simultaneously in the normal adjacent lung 
parenchyma.
DISCUSSION
Pulmonary placental transmogrification (PT) 
is a histologic diagnosis, characterized by papillary 
projections and placentoid structures with myxoid, 
l ipomatous and edematous changes; minimal 
inflammatory infiltrate and lack of pulmonary fibrosis.
Figure 3. Photomicrograph of the lung biopsy showing a well-differentiated adenocarcinoma (A - H&E, 200X; 
B - H&E, 400X) and pulmonary placental transmogrification (C - H&E, 200X; D - H&E, 400X).
PT is predominantly observed in males in 
the 2nd to the 5th decade of life. The youngest 
reported case was a 14-year-old boy with involvement 
of 2 lobes.7 The few cases that are reported in the 
literature have a wide geographical distribution with 
cases from North America, Germany, Japan, Korea, 
Portugal and India. Some patients had history of 
smoking; however, not enough data is available to 
prove an association with smoking if there is any.
Clinically, the patients may or may not be 
symptomatic.  PT usual ly  presents as bul lous 
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emphysematous disease resulting in dyspnea, chronic 
obstructive pulmonary disease, bronchopneumonia, 
and respiratory distress.2-11 It can also present as tension 
pneumothorax,12 solitary lung nodule13 and occasionally 
as incidental mass discovered by radiography.1,11 There 
is no predilection with respect to lung laterality or 
lobe.5
Pathogenesis of PT is poorly understood. As most 
of the reported cases of PT are associated with bullous 
disease, most researchers believe that PT either 
develops from bullous emphysema or is a reaction 
to it.2-4,11 Others believe that PT may be related to 
lymph-vascular malformation, owing to the frequent 
presence of lymphatic and dilated vascular channels 
within the stroma of PT.3,4 Yet others are of the opinion 
that PT is an independent lesion, possibly of congenital 
hamartomatous origin.
Our patient certainly had underlying emphysema, 
and PT morphology was classic, however, dilated 
vascular or lymphatic channels were not observed 
and due to limited core biopsy material, not enough 
tissue was available for vascular or lymphatic 
immunohistochemical markers. There was no radiologic 
or morphologic evidence of a hamartomatous lesion.
Xu et al.5 proposed that PT is associated with 
pulmonary fibrochondromatous hamartomas with 
epidemiology, morphology and pathogenic mechanism 
possibly different from PT associated with bullous 
emphysema (Table 1). In one of the largest studies on PT 
to date, Xu et al.5 tried to investigate the pathogenesis 
of PT. By evaluating the immunohistochemical profile 
of lining epithelium of PT, they proposed that the 
lining epithelium of PT is respiratory in origin and that 
the exaggerated proliferation of lining epithelial cells 
results in placental villi like structures.
In a retrospect ive study of 103 cases of 
pulmonary hamartoma and 410 cases of emphysema, 
Ortiz et al.14 found PT in 3 cases, of which 1 was 
associated with hamartoma and 2 were associated 
with emphysema. All 3 patients were male with ages 
55, 54 and 61 years, and there was no difference in 
the morphology of the 3 cases contradicting to the 
proposal of Xu et al.5
Cavazza et al.15 proposed that undifferentiated 
clear cells in the stroma of PT may be involved in the 
pathogenesis of the disease. This hypothesis, however, 
like many others is limited due to demonstration in just 
2 reported cases.
Apart from the current report, only one other 
case6 was reported in the English literature in which 
PT was associated with lung adenocarcinoma. 
Therefore no one has investigated into any possible 
relationship between PT and carcinoma.
Radiologic appearance of PT is dependent mainly 
upon the clinical presentation and weather it is 
associated with bullous emphysema or hamartoma. 
Kim et al.16 classified the radiologic appearance of 
PT into three distinct patterns: (i) bullous emphysema 
being the most common; (ii) a mixed pattern of cystic 
lesion and nodule; and (iii) the rare solitary nodule 
pattern. When a solitary nodule is identified, the 
radiographic appearance may or may not be typical of a 
hamartoma.5,17 PT can also present with typical clinical 
and radiographic appearance of tension pneumothorax 
owing to the rupture of bullae.12,18
The gross appearance varies with the disease 
process associated i.e. bullous emphysema or 
hamartoma. Those associated with bullous emphysema 
have cystic appearance with papillary projections while 
those associated with hamartomas are usually well 
circumscribed with tan-white, rubbery cut surfaces.
Table 1. Epidemiology, morphology and pathogenesis of PT
PT associated with bullous emphysema PT associated with pulmonary hamartoma
Predominantly males during 2nd to 5th decade of life. Relatively older asymptomatic patients. No gender predilection.
Placentoid structures with prominent lymph-vascular 
proliferation and dilation. Placentoid structures with prominent fibroadipose stroma.
Reaction to emphysema / lymph-vascular malformation. Exaggerated proliferation of lining epithelial cells / congenital hamartomatous origin.
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Microscopically PT is composed of immature 
placental villi in a myxoid or edematous stroma. 
The s t roma i s  composed of  l ymph-vascu la r 
channels,3,4 fibroadipose tissue,5 interstitial clear 
cells15 and in rare instances the adipose tissue 
comprises the major bulk of the stroma.10
PT is a benign lesion and surgery is usually 
curative. Brevetti et al.19 favored minimal resection 
and avoidance of lobectomy. This approach of 
minimal resection, however, is dependent on extent 
of underlying bullous disease and size of hamartoma 
/ nodule, and in cases where it is associated with 
carcinoma (Hano et al.6 and current case) the extent 
of surgery is dictated by tumor stage.
As with the treatment, prognosis depends 
on  unde r l y ing  a s soc i a ted  d i sease  p roces s . 
Recurrence is not known. Limited follow up data is 
available. 3 patients from experience of Ortiz et al.14 
had a mean follow of 72 months with no evidence of 
recurrent disease or new tumors in other locations. 
Another patient reported by Shapiro et al.20 showed 
relief of respiratory symptoms following surgery and 
at 2 year follow up. Our patient was alive and doing 
well except for complications of her multiple chronic 
diseases 7 months post diagnosis.
CONCLUSION
The notion that PT is a benign lesion may not be 
true anymore. Although most cases are associated 
with bullous lesions of lung and fibrochondromatous 
hamartomas, the possibility of adenocarcinoma needs 
to be ruled out for adequate patient management. 
Also, since it has been proposed with evidence that 
PT is due to exuberant proliferation of lining epithelial 
cells, studies need to be carried out to confirm 
if PT represents an intermediate stage in progression 
of benign lesions to carcinoma.
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